Transferrin Ensures Survival of Ovarian Carcinoma Cells Subjected to Deferoxamine, TNFA, FASL, Trail or MYC-Activation

• Sandra Fassl,
• Georg Rosenberger,
• Michael Grusch,
• Gerhard Fuhrmann,
• Katharina Leuhuber,
• Doris Polgar,
• Georg Krupitza

Affiliations

Sandra Fassl

Institute of Clinical Pathology, University of Vienna, A-1090 Vienna, Austria

Georg Rosenberger

Institute of Clinical Pathology, University of Vienna, A-1090 Vienna, Austria

Michael Grusch

Institute of Clinical Pathology, University of Vienna, A-1090 Vienna, Austria

Gerhard Fuhrmann

Institute of Clinical Pathology, University of Vienna, A-1090 Vienna, Austria

Katharina Leuhuber

Institute of Clinical Pathology, University of Vienna, A-1090 Vienna, Austria

Doris Polgar

Institute of Clinical Pathology, University of Vienna, A-1090 Vienna, Austria

Georg Krupitza

Institute of Clinical Pathology, University of Vienna, A-1090 Vienna, Austria